Network pharmacology and in vivo studies reveal the pharmacological effects and molecular mechanisms of Celastrol against acute hepatic injury induced by LPS

T Yang, S Zhao, N Sun, Y Zhao, H Wang… - International …, 2023 - Elsevier
Sepsis is currently the main factor of death in the ICU, and the liver, as an important organ of
immunity and stable metabolism, can be acutely damaged during sepsis, and the mortality …

[HTML][HTML] Celastrol aggravates LPS-induced inflammation and injuries of liver and kidney in mice

M Wu, W Chen, X Yu, D Ding, W Zhang… - American journal of …, 2018 - ncbi.nlm.nih.gov
Sepsis, a life-threatening syndrome with uncontrolled inflammatory response, causes high
morbidity and mortality worldwide. Currently, satisfactory treatments on sepsis are still …

Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis

X Li, S Wei, S Niu, X Ma, H Li, M Jing, Y Zhao - Computers in biology and …, 2022 - Elsevier
Abstract Background Huanglian Jiedu Decoction (HLJDD) is a classical herbal formula with
potential efficacy in the treatment of sepsis. However, the main components and potential …

Celastrol alleviates autoimmune hepatitis through the PI3K/AKT signaling pathway based on network pharmacology and experiments

S Wang, Z Huang, Y Lei, X Han, D Tian… - Frontiers in …, 2022 - frontiersin.org
Objective: This work aims to explore the potential targets and underlying therapeutic
mechanisms of celastrol in autoimmune hepatitis (AIH) through network pharmacology and …

Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice

L Ma, X Gong, G Kuang, R Jiang, R Chen… - … and biophysical research …, 2015 - Elsevier
Sesamin has been described to exert anti-oxidant and anti-inflammatory properties. In
present study, we investigated the potential effects and mechanisms of sesamin on …

[HTML][HTML] The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury

S Tang, X Zhang, Z Duan, M Xu, M Kong… - International …, 2023 - Elsevier
Abstract Background & Aims Silibinin-phospholipid complex (SPC) has been utilized to treat
acute liver injury clinically. Nevertheless, the hepatoprotective mechanism of SPC remains …

Protective effect of wedelolactone against CCl4-induced acute liver injury in mice

Y Lu, DM Hu, SB Ma, X Zhao, S Wang, G Wei… - International …, 2016 - Elsevier
Eclipta, a traditional Chinese medicine, has been used to treat liver disease for centuries.
However, the chemical basis and biological mechanisms of Eclipta remain elusive. The …

In silico target fishing for the potential bioactive components contained in Huanglian Jiedu Tang (HLJDD) and elucidating molecular mechanisms for the treatment of …

MA Shi-Tang, F Cheng-Tao, DAI Guo-Liang… - Chinese journal of …, 2015 - Elsevier
The present study was designed to target fish for potential bioactive components contained
in a Huang Lian Jie Du decoction (HLJDD) and identify the underlying mechanisms of action …

Puerarin Prevents Acute Liver Injury via Inhibiting Inflammatory Responses and ZEB2 Expression

J Yang, M Wu, H Fang, Y Su, L Zhang… - Frontiers in …, 2021 - frontiersin.org
Puerarin, an isoflavone component extracted from herb radix puerariae, is widely used in
China in the treatment of immune diseases and inflammation. Previous studies have …

Naringenin inhibits APAP-induced acute liver injury through activating PPARA-dependent signaling pathway

J Xu, J Chen, J Deng, X Chen, R Du, Z Yu… - Experimental Cell …, 2024 - Elsevier
Acute liver injury (ALI) refers to the damage to the liver cells of patients due to drugs, food,
and diseases. In this work, we used a network pharmacology approach to analyze the …